We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01078337
First Posted: March 2, 2010
Last Update Posted: March 2, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Stanford University
February 26, 2010
March 2, 2010
March 2, 2010
November 2002
October 2007   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis
T-cell MRD Evaluation Using Flow Cytometric Analysis
To determine if MRD (minimal residual disease) can be found in the blood (only) as opposed to bone marrow in children with ALL (acute lymphoblastic leukemia).
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
blood and bone marrow
Non-Probability Sample
children with newly diagnosed T-cell ALL
Leukemia, Lymphocytic, Acute
  • Procedure: bone marrow aspiration
  • Procedure: peripheral blood sampling
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
15
October 2007
October 2007   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Children with newly diagnosed T-cell ALL
Sexes Eligible for Study: All
up to 18 Years   (Child, Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01078337
SU-11022007-790
PEDSALL0001
Not Provided
Not Provided
Not Provided
Gary V Dahl, Stanford University School of Medicine
Stanford University
Not Provided
Principal Investigator: Gary V Dahl Stanford University
Stanford University
February 2010